Table 2.

Differences in processes of care between states with and without public reporting

	Mandated Public Reporting
	No	Yes	P-Value*
Red Blood Cell Transfusion	31,856 (2.7%)	3,747 (2.4%)	<0.001
PCI performed with Large Contrast Volume	307,902 (30.5%)	42,567 (29.6%)	<0.001
Door to balloon time (in patients with immediate PCI for STEMI), minutes, median (25th,75th percentiles)
Discharge Medications in Patients Discharged Alive	62 (47, 78)	62 (46, 78)	0.87
ACE-Inhibitor/ARB	743,411 (63.7%)	94,651 (61.5%)	<0.001
Aspirin	1,109,767 (95.0%)	148,950 (96.8%)	<0.001
Beta Blockers	944,403 (80.9%)	130,807 (85.0%)	<0.001
Statin	1,011,008 (86.6%)	137,003 (89.1%)	<0.001
Non-Statin	189,742 (16.3%)	22,199 (14.4%)	<0.001
Any Thienopyridines	1,113,558 (96.3%)	148,121 (97.0%)	<0.001
Clopidogrel	971,065 (83.2%)	132,979 (86.5%)	<0.001
Ticlopidine	3,877 (0.3%)	625 (0.4%)	<0.001
Prasugrel	141,028 (12.1%)	14,908 (9.7%)	<0.001

^*All tests compare public reporting states to non-public reporting states within each rows’ designated group (e.g. All patients in public reporting states versus all patients in non-public reporting states).